Kamada Ltd. (KMDA)
NASDAQ: KMDA · Real-Time Price · USD
7.64
-0.05 (-0.65%)
Oct 14, 2026, 11:00 AM EDT - Market open
Kamada Employees
Kamada had 462 employees as of December 31, 2025. The number of employees increased by 42 or 10.00% compared to the previous year.
Employees
462
Change (1Y)
42
Growth (1Y)
10.00%
Revenue / Employee
$415,258
Profits / Employee
$48,165
Market Cap
444.34M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 462 | 42 | 10.00% |
| Dec 31, 2024 | 420 | 42 | 11.11% |
| Dec 31, 2023 | 378 | -2 | -0.53% |
| Dec 31, 2022 | 380 | 25 | 7.04% |
| Dec 31, 2021 | 355 | -53 | -12.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evotec SE | 4,461 |
| Tilray Brands | 3,595 |
| Canopy Growth | 1,128 |
| Aurora Cannabis | 1,028 |
| Emergent BioSolutions | 900 |
| Glass House Brands | 426 |
| Evolus | 353 |
| Anika Therapeutics | 235 |
KMDA News
- 8 days ago - Kamada launches two new biosimilar products in Israel - TheFly
- 8 days ago - Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel - GlobeNewsWire
- 16 days ago - Kamada (NASDAQ:KMDA) -- Growth Potential in Biopharmaceuticals | Renaissance Investment ... - GuruFocus
- 17 days ago - Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth - MarketBeat
- 20 days ago - Kamada Transcript: Small-Cap Virtual Conference - Transcripts
- 26 days ago - Kamada Ltd (KMDA) Director David Tsur Sells 22,827 Shares - GuruFocus
- 27 days ago - Kamada Confirms KedRAB Supply As U.S. Rabies Exposures Increase - Nasdaq
- 27 days ago - Kamada confirms sufficient KedRAB supply amid increased demand - TheFly